Dear Colleagues,
The Multipurpose Prevention Technologies (MPTs) field is steadily evolving and expanding. Provided below are links to recent publications, media articles, and other resources relevant to MPTs to keep you up-to-date. Please note that contents are neither endorsed by nor necessarily represent the views of the Initiative for Multipurpose Prevention Technologies (IMPT), and that due to publication copyright and permissions restrictions, full-text versions of resources may not be publicly available.
Best,
IMPT Secretariat Staff
|
|
Announcements
Join the IMPT on Thursday, 28 September 2017 at 7:00 a.m. PT / 10:00 a.m. ET / 15:00 BST / 16:00 CEST / 16:00 SAST for the final webinar in a series of this year's webinars about critical issues in the rapidly developing MPT field: "MPT End-User Research: Updates from the Field."
This 60-minute webinar will focus on the priority area of research in order to better understand the MPT end-user context. It will highlight new research exploring the acceptability of and preference between potential MPT product types, drivers of future product use, and other important end-user considerations. To register, click
here
.
|
Journal Articles
Divergent Preferences for HIV Prevention: A Discrete Choice Experiment for Multipurpose HIV Prevention Products in South Africa. Quaife, M., Eakle, R., Cabrera Escobar, M.A., Vickerman, P., Kilbourne-Brook, M., ... Terris-Prestholt, F. (2017, September 1). Medical Decision Making.
|
RFA-AI-17-028
Next Generation Multipurpose Prevention Technologies (NGM) (R61/R33 - Clinical Trials Optional) - NIAID and NIMH will be accepting applications to support the development of new and innovative multipurpose prevention technologies (MPTs) with the dual purpose of contraception and HIV prevention.
View the link above for
more detailed information. Letters of Intent due February 19, 2018.
Also, stay tuned as the IMPT will highlight technical priorities and gaps in the MPT field that may align with the scope of this RFA.
|
|
|
|
|
